W. Michael Kavanaugh
2016
In 2016, W. Michael Kavanaugh earned a total compensation of $1.4M as Chief Scientific Officer and Head of Research and Non- Clinical Development at CytomX Therapeutics, a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $193,607 |
|---|---|
| Option Awards | $786,968 |
| Salary | $395,117 |
| Other | $6,564 |
| Total | $1,382,256 |
Kavanaugh received $787K in option awards, accounting for 57% of the total pay in 2016.
Kavanaugh also received $193.6K in non-equity incentive plan, $395.1K in salary and $6.6K in other compensation.
Rankings
In 2016, W. Michael Kavanaugh's compensation ranked 6,660th out of 14,075 executives tracked by ExecPay. In other words, Kavanaugh earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,660 out of 14,075 | 53rd |
Division Manufacturing | 2,479 out of 5,489 | 55th |
Major group Chemicals And Allied Products | 808 out of 1,895 | 57th |
Industry group Drugs | 620 out of 1,538 | 60th |
Industry Pharmaceutical Preparations | 490 out of 1,176 | 58th |
Source: SEC filing on May 9, 2017.
Kavanaugh's colleagues
We found three more compensation records of executives who worked with W. Michael Kavanaugh at CytomX Therapeutics in 2016.